Gurit Holding AG (0QQR)
London Stock Exchange · UK · prices in GBP · close of 27 Oct 2026
Key indicators
| Last close | GBP 46.50 |
|---|---|
| 52-week range | 10.20 – 61.00 |
| Return, 1 month / 3 months | −19.6% / +54.5% |
| Return, 1 year / 3 years | +315.2% / −33.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 40 |
| Volatility (1 year) | 74.2% |
| Worst drawdown (1 year) | -39.3% |
| Average daily value traded | 0.10M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gurit Holding AG is a Swiss company that makes composite materials and related products. It supplies prepregs, core materials, adhesives and tooling to manufacturers, with customers in wind energy, marine, automotive and aerospace markets. The company also provides engineering services for composite components. Its operations are based in Switzerland, and it serves industrial customers around the world.
Gurit Holding AG trades under the code 0QQR on the London Stock Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gurit Holding AG (0QQR) trades on the London Stock Exchange in UK. It last closed at GBP 46.50 on 27 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,445 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 315.2% and over the last three months it rose 54.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 28.1% | ||
| From 52-week high | -23.8% | ||
| Momentum | 95 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 54.5% | ||
| 6-month return | 29.4% | ||
| 12-month return, skipping the last month | 416.1% | ||
| Stability (higher is calmer) | 22 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 74.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.3% | ||
| Liquidity | 30 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.10M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −8.8% |
|---|---|
| 1 month | −19.6% |
| 3 months | +54.5% |
| 6 months | +29.4% |
| 1 year | +315.2% |
| 3 years | −33.1% |
| 5 years | −71.7% |
Signals
| 50-day / 200-day average | 49.14 / 36.30 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Apr 2024 | GBX 0.0035 |
| 22 Apr 2022 | GBX 0.0700 |
| 16 Apr 2021 | GBX 0.3000 |
| 17 Apr 2020 | GBX 0.2500 |
| 11 Apr 2019 | GBX 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.